Resveratrol Has Anabolic Effects on Disc Degeneration in a Rabbit Model

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2013 Jun 18

PMID 23772162

Citations 12

Authors

Young-Joon Kwon

Affiliations

Soon will be listed here.

Abstract

This study was done to evaluate whether injections of resveratrol, a natural compound found in the skin of grapes, had anabolic effects on degenerated intervertebral discs in a rabbit model. Two non-continuous lumbar discs were punctured in rabbits to induce disc degeneration. Four weeks and 6 weeks after puncture, the rabbits were treated by injections with dimethylsulfoxide (DMSO) or resveratrol. At 4, 8, and 16 weeks after initial injection, rabbits were sacrificed and the spine was extracted for magnetic resonance image (MRI), mRNA expression, and histological staining. Resveratrol treatment resulted in stronger signal intensity in T2-weighted images. MRI grade showed significantly lower in the resveratrol group than the DMSO group (P = 0.039). In the resveratrol group, aggrecan gene expression was significantly increased than that in the DMSO group at 16 weeks after injection (P = 0.027). MMP-13 mRNA levels in the resveratrol group were significantly decreased than those in the DMSO group at 8 and 16 weeks (P = 0.006 and P = 0.048, respectively). In hematoxylin and eosin stain, resveratrol-treated discs showed the features of regeneration. Histologic grade revealed improvement in resveratrol-treated discs, compared with DMSO-treated discs (P = 0.024). These anabolic effects on degenerated discs indicate that resveratrol is a promising candidate for treatment of degenerative disc disease.

Citing Articles

Animal Models of Intervertebral Disc Diseases: Advantages, Limitations, and Future Directions.

Hong J, Kim H, Jeon W, Yeo C, Kim H, Lee J Neurol Int. 2024; 16(6):1788-1818.

PMID: 39728755 PMC: 11678881. DOI: 10.3390/neurolint16060129.

The anti-oxidation related bioactive materials for intervertebral disc degeneration regeneration and repair.

Mai Y, Wu S, Zhang P, Chen N, Wu J, Wei F Bioact Mater. 2024; 45:19-40.

PMID: 39588482 PMC: 11585838. DOI: 10.1016/j.bioactmat.2024.10.012.

Plant-Derived Senotherapeutics for the Prevention and Treatment of Intervertebral Disc Degeneration and Aging.

Mavrogonatou E, Kletsas D Metabolites. 2024; 14(3).

PMID: 38535306 PMC: 10971879. DOI: 10.3390/metabo14030146.

Intervertebral disc degeneration-Current therapeutic options and challenges.

Samanta A, Lufkin T, Kraus P Front Public Health. 2023; 11:1156749.

PMID: 37483952 PMC: 10359191. DOI: 10.3389/fpubh.2023.1156749.

Pharmacological Effects of Resveratrol in Intervertebral Disc Degeneration: A Literature Review.

Liu M, Zhang L, Zang W, Zhang K, Li H, Gao Y Orthop Surg. 2022; 14(12):3141-3149.

PMID: 36303427 PMC: 9732612. DOI: 10.1111/os.13560.

References

Urban J, MCMULLIN J . Swelling pressure of the inervertebral disc: influence of proteoglycan and collagen contents. Biorheology. 1985; 22(2):145-57. DOI: 10.3233/bir-1985-22205. View

Makarov S . NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res. 2001; 3(4):200-6. PMC: 128895. DOI: 10.1186/ar300. View

Freemont T, Lemaitre C, Watkins A, Hoyland J . Degeneration of intervertebral discs: current understanding of cellular and molecular events, and implications for novel therapies. Expert Rev Mol Med. 2004; 2001:1-10. DOI: 10.1017/S1462399401002885. View

Masuda K, Imai Y, Okuma M, Muehleman C, Nakagawa K, Akeda K . Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine (Phila Pa 1976). 2006; 31(7):742-54. DOI: 10.1097/01.brs.0000206358.66412.7b. View

Moon S, Gilbertson L, Nishida K, Knaub M, Muzzonigro T, Robbins P . Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: implications for the clinical management of intervertebral disc disorders. Spine (Phila Pa 1976). 2000; 25(20):2573-9. DOI: 10.1097/00007632-200010150-00006. View

Sobajima S, Kompel J, Kim J, Wallach C, Robertson D, Vogt M . A slowly progressive and reproducible animal model of intervertebral disc degeneration characterized by MRI, X-ray, and histology. Spine (Phila Pa 1976). 2005; 30(1):15-24. DOI: 10.1097/01.brs.0000148048.15348.9b. View

Wuertz K, Quero L, Sekiguchi M, Klawitter M, Nerlich A, Konno S . The red wine polyphenol resveratrol shows promising potential for the treatment of nucleus pulposus-mediated pain in vitro and in vivo. Spine (Phila Pa 1976). 2011; 36(21):E1373-84. DOI: 10.1097/BRS.0b013e318221e655. View

Sun C, Hu Y, Liu X, Wu T, Wang Y, He W . Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis. Cancer Genet Cytogenet. 2006; 165(1):9-19. DOI: 10.1016/j.cancergencyto.2005.06.016. View

Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian H . Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood. 2003; 102(3):987-95. DOI: 10.1182/blood-2002-11-3550. View

10.

Hoyland J, Le Maitre C, Freemont A . Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxford). 2008; 47(6):809-14. DOI: 10.1093/rheumatology/ken056. View

11.

Wehling N, Palmer G, Pilapil C, Liu F, Wells J, Muller P . Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum. 2009; 60(3):801-12. PMC: 2688727. DOI: 10.1002/art.24352. View

12.

Li X, Phillips F, An H, Ellman M, Thonar E, Wu W . The action of resveratrol, a phytoestrogen found in grapes, on the intervertebral disc. Spine (Phila Pa 1976). 2008; 33(24):2586-95. PMC: 2905225. DOI: 10.1097/BRS.0b013e3181883883. View

13.

Shakibaei M, Csaki C, Nebrich S, Mobasheri A . Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol. 2008; 76(11):1426-39. DOI: 10.1016/j.bcp.2008.05.029. View

14.

Anderson D, Izzo M, Hall D, Vaccaro A, Hilibrand A, Arnold W . Comparative gene expression profiling of normal and degenerative discs: analysis of a rabbit annular laceration model. Spine (Phila Pa 1976). 2002; 27(12):1291-6. DOI: 10.1097/00007632-200206150-00009. View

15.

Csaki C, Keshishzadeh N, Fischer K, Shakibaei M . Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol. 2007; 75(3):677-87. DOI: 10.1016/j.bcp.2007.09.014. View

16.

Masuda K, Aota Y, Muehleman C, Imai Y, Okuma M, Thonar E . A novel rabbit model of mild, reproducible disc degeneration by an anulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine (Phila Pa 1976). 2005; 30(1):5-14. DOI: 10.1097/01.brs.0000148152.04401.20. View

17.

Kandel R, Roberts S, Urban J . Tissue engineering and the intervertebral disc: the challenges. Eur Spine J. 2008; 17 Suppl 4:480-91. PMC: 2587666. DOI: 10.1007/s00586-008-0746-2. View

18.

Miagkov A, Kovalenko D, Brown C, Didsbury J, Cogswell J, Stimpson S . NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A. 1998; 95(23):13859-64. PMC: 24931. DOI: 10.1073/pnas.95.23.13859. View

19.

Sobajima S, Shimer A, Chadderdon R, Kompel J, Kim J, Gilbertson L . Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. Spine J. 2005; 5(1):14-23. DOI: 10.1016/j.spinee.2004.05.251. View

20.

Hohaus C, Ganey T, Minkus Y, Meisel H . Cell transplantation in lumbar spine disc degeneration disease. Eur Spine J. 2008; 17 Suppl 4:492-503. PMC: 2587656. DOI: 10.1007/s00586-008-0750-6. View